Jupiter Neurosciences, Inc. , a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation.
Jupiter Neurosciences stock last closed at $1.13, up 0.89% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Jupiter Neurosciences stock is currently +121.57% from its 52-week low of $0.51, and -94.21% from its 52-week high of $19.51.
There are currently 33.1M shares of JUNS outstanding. The market capitalization of JUNS is $37.41M. In the last 24 hours, 539,000 JUNS shares were traded.
How to Buy Jupiter Neurosciences Stock
Not sure how to invest in Jupiter Neurosciences stock? Here's how.
Choose where to buy Jupiter Neurosciences stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Jupiter Neurosciences stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit funds into your investment account: Select your method of payment and add your information.
Evaluate Jupiter Neurosciences stock: The Jupiter Neurosciences ticker symbol is JUNS. Is Jupiter Neurosciences stock a good investment? Should you buy shares of JUNS? How do JUNS's underlying business fundamentals look? Do top analysts think Jupiter Neurosciences is a good buy? Why has JUNS's stock price moved recently? (Hint: Our stock market research website can help you figure out if JUNS is a good stock to buy).
Make your JUNS buy order: Decide if you will purchase JUNS shares at the current market price or use a limit order to buy JUNS stock at a specific price.
Keep an eye on your investment in JUNS: Create a watchlist to watch your new investment in Jupiter Neurosciences stock.
Step 1: Choose where to buy Jupiter Neurosciences stock
You will need a brokerage account in order to access the NASDAQ market and buy JUNS shares.
A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global markets: From Tech to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in JUNS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Jupiter Neurosciences stock
After you have figured out the best place to buy Jupiter Neurosciences stock, it's important to analyze their stock prior to investing, so you can comprehend the risk as well as the opportunity.
Overview of key JUNS info
JUNS Price
$1.13
1w %
44.87%
1y %
N/A
5y %
N/A
P/E
-10.27x
P/B
12.21x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$3.33M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$37.41M
Next Earnings
N/A
Next Dividend
N/A
Fundamentals of Jupiter Neurosciences
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
Last year, JUNS revenue was $0.00. During the past 2 year, JUNS's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 43.24%.
No, Jupiter Neurosciences doesn't provide an income stream by paying out dividends.
What do other investors have to say about JUNS?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your JUNS buy order
You have two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly sufficient.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at an exact dollar amount limit, use a limit order.
Hit the Open button and your broker will execute your order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Jupiter Neurosciences share?
As of Jun 13, 2025, it costs $1.13 to buy one share of Jupiter Neurosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.57, you can buy 0.5 shares of JUNS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.